Find out which vaccines are recommended while you're pregnant to protect you and your baby, and which you'll need to wait on.

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new drug that protects against RSV, a common cold-like virus that can cause ...

Since the start of February, pregnant women have been eligible to get vaccinated against respiratory syncytial virus (RSV).  The vaccine is administered during the 28 to 36 week mark of pregnancy to ...

The online tool CoVerage can detect and characterize SARS-CoV-2 Variants of Concern (VOCs) up to three months before their formal designation of the WHO.

Five risk factors explain 50 per cent of cardiovascular risk at age 50, according to a new study.  Addressing those risk factors can add years to your life, even if you address them in middle age. ...